
|Podcasts|September 26, 2022
Pharmacy Focus: Oncology Edition - Experts See Promising Future for the Treatment of Acute Lymphoblastic Leukemia
CAR T therapies are potentially revolutionizing the treatment of acute lymphoblastic leukemia (ALL).
Advertisement
This month, we spoke with Craig Freyer, PharmD, BCOP, clinical pharmacy specialist at Penn Medicine, to learn about how CAR T therapies are potentially revolutionizing the treatment of acute lymphoblastic leukemia (ALL). In addition to discussing what makes ALL treatment unique from other cancer treatments, Freyer said pharmacists have important roles to play in managing cytokine release syndrome and potential neuro-toxicities.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
The Peptide Reclassification Everyone's Talking About: A Pharmacist's Take on What RFK Jr's Announcement Actually Means
2
Brain Inflammation May Not Drive Persistent Long COVID Symptoms, New Imaging Study Finds
3
Adults With Schizophrenia Remain Stable When Transitioning from Atypical Antipsychotic to Cobenfy
4
Beyond Weight Loss: Exploring the Renal and Anti-Inflammatory Benefits of High-Dose Semaglutide
5






































































































































